Wilm's Tumor 1 Protein Vaccine to Treat Cancers of the Blood

Conditions:   Leukemia, Acute Myelogenous (AML);   Leukemia, Acute Lymphocytic (ALL);   Leukemia, Chronic Myelogenous (CML);   Myelodysplastic Syndrome (MDS);   Non-Hodgkin's Lymphoma (NHL)Interventions:   Drug: WT1 Peptide-Pulsed Dendritic Cells;   Drug: Donor Lymphocytes;   Drug: IL-4;   Drug: KLH;   Drug: WT1 Peptides;   Drug: EndotoxinSponsors:   National Institutes of Health Clinical Center (CC);   National Cancer Institute (NCI)Recruiting - verified December 2012
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials